groin hematoma, femoral pseudoaneurysm, and arteriovenous fistula. 22 Overall complication rates up to 8.3% have been reported in embolization for meningiomas. 13 The optimal time interval between tumor embolization and resection is also unknown. Some studies have recommended a minimum of 24 hours if the goal is to simply maximize tumor devascularization and reduce operative blood loss and at least a week when trying to optimize tumor resectability and decrease edema. 10, 19, 33 In contrast, other authors have suggested intervals of less than a week to reduce the opportunity for tumor revascularization. 26, 30 In the current work, using a large national database, we studied the impact of immediate preoperative embolization on the immediate outcomes of meningioma resection.
Methods
A retrospective observational study was performed using the National (Nationwide) Inpatient Sample (NIS) for the period between 2002 and 2014. The NIS is a database publicly available through the Healthcare Cost and Utilization Project (HCUP; https://www.hcup-us.ahrq.gov/ nisoverview.jsp). It is the largest administrative all-payer database in the US, representing a 20% stratified sample of all US hospital discharges. Patient diagnoses and treatments are recorded using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes.
Inclusion and Exclusion Criteria
The database was queried for all meningioma patients (diagnosis codes: 192.1, 225.2, 237.6) who had undergone craniotomy (procedure code: 01.51). Patients undergoing tumor embolization (procedure code: 39.72) in the same admission were identified. The NIS provides a "PRDAYn" variable that identifies on which day of hospitalization each procedure occurs. Therefore, patients with a PRDAYn missing for embolization or resection or patients who had an embolization day following the resection day were excluded in order to identify the preoperative embolization patients.
The primary exposure of interest was preoperative embolization for meningioma. Patient variables included tumor histology (benign or malignant), age, sex, race (white, black, Hispanic, Asian or Pacific Islander, or other), Charlson Comorbidity Index (CCI), insurance status (Medicare or private, Medicaid, or no coverage), and zip code income quartile. Admissions were categorized as elective or nonelective. The All-Patient Refined Diagnosis-Related Group (APR-DRG) index was used to represent disease severity. 3 Hospital variables included region (Northeast, Midwest, South, West), location and teaching status (rural, urban nonteaching, urban teaching), and size (small, medium, or large).
Studied outcomes included morbidity, mortality, and discharge disposition. Complications were derived from previously defined adverse events of meningioma resection 1 and endovascular embolization, including hematoma complicating a procedure, cerebral infarction or hemorrhage, hydrocephalus, cerebral edema, cranial nerve palsy, meningitis or cerebral venous thrombosis, venous embolism, blood transfusion, and mechanical ventilation. Discharge disposition was categorized as routine, nonroutine (discharge to skilled nursing facility, acute rehabilitation facility, hospice, short-term hospital, or home health care), or in-hospital death.
Statistical Analysis
Statistical analysis was performed using Stata/MP version 14.1 (StataCorp LLC). Continuous variables are presented as the means ± standard deviations, and categorical variables are presented as counts with corresponding percentages. Independent samples t-tests and Wilcoxon ranksum tests were used to detect group differences for normally and nonnormally distributed continuous variables, respectively. The chi-square test was used for categorical variables, and ordinal logistic regression was used for ordinal variables. Multivariate logistic regression analyses were completed to determine the impact of the interval between embolization and resection on these outcomes. Statistical significance was defined as α = 0.05, and all tests were 2-sided. In accordance with the HCUP data use agreement, cells containing ≤ 10 patients are not reported as a patient privacy precaution.
Given significant differences between the embolization and nonembolization patient cohorts, we used propensity score matching to adjust for differences in patient and hospital characteristics. Multivariate logistic regression was used to estimate the propensity of preoperative embolization (compared with no preoperative embolization). Covariates were selected a priori and included age, sex, race, insurance status, zip code income quartile, CCI, APR-DRG index, elective status of the admission, hospital size, hospital region, hospital location, and hospital teaching status. Matched propensity score analysis was completed with a 1:1 nearest neighbor algorithm without replacement using the TEFFECTS and PSMATCH2 software modules in Stata. 14 These matching methods were selected to minimize bias. 2 Patients who had undergone preoperative embolization were then matched to patients who had not, according to the propensity score. Following propensity score matching, rates of adverse outcomes were compared using chi-square tests.
Results
Overall, 27,008 meningioma admissions met the inclusion criteria, and 633 patients (2.34%) had undergone preoperative embolization and 26,375 (97.66%) had not. Baseline characteristics for both the overall and the propensity score-matched cohorts are shown in Tables 1 and  2 . Several baseline differences were observed in the overall cohort, including a lower age (55.17 vs 57.69 years, p < 0.001) and a smaller proportion of females (63.5% vs 69.1%, p = 0.003) among the embolization patients. The embolization patients also had higher CCIs (OR 1.27, p = 0.002) and APR-DRG disease severity (OR 1.68, p < 0.001).
Unmatched Cohort
In the overall cohort, preoperative embolization was associated with significantly increased rates of hematoma complicating a procedure (3.6% vs 1.7%, p < 0.001), infarction or hemorrhage (7.6% vs 3.8%, p < 0.001), hydrocephalus (8.8% vs 4.1%, p < 0.001), cerebral edema (27.6% vs 11.8%, p < 0.001), meningitis or cerebral venous thrombosis (≤ 1.6% vs 0.6%, p = 0.049), and venous embolism (3.8% vs 1.8%, p < 0.001). Embolization patients also had higher rates of posthemorrhagic anemia or transfusion (21.8% vs 11.4%, p < 0.001), mechanical ventilation (9.0% vs 5.6%, p < 0.001), and nonroutine discharge (42.0% vs 33.3%, p < 0.001). There were no differences in the rates of cranial nerve palsy or death (Table 3) .
Interval Analysis
Univariate and multivariate logistic regression analyses restricted to embolization patients were completed to determine the impact of the interval (days) before resection on adverse outcomes. The mean interval was 1.49 days (range 0-20 days). Covariates included the patient and hospital factors previously described. On univariate analysis, a longer interval was significantly associated with an increased risk for infarction or hemorrhage (OR 1.14, p = 0.022) and nonroutine discharge (OR 1.31, p < 0.001). On adjusted analysis, only the association with nonroutine discharge remained significant (OR 1.33, p = 0.004).
Matched Cohort
After 1:1 propensity score matching, 413 embolization patients and 413 nonembolization patients were retained for comparison (Table 2 ). In this matched cohort, preoperative embolization was associated with increased rates of cerebral edema (25.2% vs 17.7%, p = 0.009), posthemorrhagic anemia or transfusion (21.8% vs 13.8%, p = 0.003), and nonroutine discharge (42.8% vs 35.7%, p = 0.039). There were no other significant associations (Table 4) .
Discussion
Using the NIS database, we completed a retrospec- tive analysis of meningioma patients who had undergone resection with or without immediate preoperative embolization. Consistent with its goal of decreasing surgical complexity, preoperative embolization was more likely to be performed in patients with comorbid conditions and higher disease severity indices. When adjusting for hospital and patient factors (excluding tumor-specific information not in the NIS database, such as size, location, and arterial feeders), we found that patients who had undergone preoperative embolization had a 47% increased risk of cerebral edema, 92% increased risk of posthemorrhagic anemia or transfusion, and 7% increased risk for nonroutine discharge. In contrast, there were no differences for other complications, such as cranial nerve palsy, cerebral infarction or hemorrhage, and death.
Because preoperative embolization is more likely to be performed for large, 29 vascular meningiomas with difficultto-access feeding arteries, 12 the increased risks for cerebral edema, blood loss, and adverse discharge are not necessarily surprising. Nonetheless, such tumor characteristics represent a confounding variable by indication, where a variable is associated with both the exposure and the outcome. 31, 32 While our use of propensity score matching minimized confounding of the measured variables available in the NIS database, it did not preclude confounding by unmeasured variables, such as individual surgeon preferences or tumor characteristics. Given this limitation, our data suggest that complex meningiomas thought to require preoperative embolization represent a clinical entity distinct from those meningiomas that appear resectable without preoperative treatment. Nonetheless, preoperative embolization and resection of such complex meningiomas can be safely performed in the majority of cases.
The higher rate of cerebral edema we observed in the embolization patients (25.2% vs 17.7% in the matched cohort) is consistent with rates in prior studies 8, 21, 36, 37 and likely results from a combination of the increased complexity of tumors selected for embolization and an effect of the embolization itself. 34 Pretreatment edema exists in up to two-thirds of meningioma patients and varies with tumor location, tumor size, and extent of cortical dam- Values expressed as the mean ± standard deviation or as number (%), unless indicated otherwise.
» CONTINUED FROM PREVIOUS COLUMN
age. 8, 17, 18, 24 Larger meningiomas and those located in the frontal convexity or middle third falx have been shown to have significantly greater edema. 24 Therefore, while embolization is known to be associated with cerebral edema, 34 many of the patients in our study probably had baseline edema before embolization or resection. Unfortunately, the timing and cause of this edema cannot be directly ascertained from our data set. However, abnormal imaging results (such as cerebral edema) are only coded for billing and only appear in the NIS database with documented clinical significance, 9 and those patients with baseline symptomatic edema not reflected in the CCI and APR-DRG index were almost certainly more likely to have had deeper or larger tumors that would be selected for preoperative embolization.
To our knowledge, this is the first report of a greater incidence of nonroutine discharge disposition among meningioma patients who underwent preoperative embolization than that among nonembolized patients. Because this finding persisted on adjusted analysis-unlike complications of embolization, such as stroke or hemorrhage-it probably represents a meaningful clinical impact of the increased complexity of tumors selected for embolization. Therefore, further care of cerebral edema in complex meningioma patients may be required for clinical manifestations such as nausea and vomiting, altered mental status, or decreased respiratory drive. Prolonged care following hospital discharge also probably increases costs for both patients and health care systems and should be considered when planning treatment.
Together, our data suggest that meningiomas selected for preoperative embolization represent a subset of highrisk tumors and that patients with these tumors have extra clinical needs. Surgical and postoperative care for these patients should be planned accordingly and the costs perhaps reimbursed differently than those for simple menin- giomas. Future longitudinal studies are needed to determine if there are associations between preoperative embolization and long-term outcomes for meningioma patients. The interval between embolization and craniotomy is also a controversial topic, with mixed recommendations and evidence for impact on efficacy or patient outcomes. 4, 5, 10, 12, 19, 30, 35 However, embolization and resection are usually completed within 72 hours of each other and within the same hospital stay. 11 In the current analysis, we identified delayed resection as a risk factor for cerebral infarction or hemorrhage, although this relation did not persist on multivariate analysis. However, there was a significant association between a longer interval and nonroutine discharge on both unadjusted and adjusted analyses. Given that delayed resection does not appear to be associated with an increased risk of in-hospital complications, the timing of surgery following embolization can be largely determined according to surgeon discretion.
There are several limitations to retrospective analyses utilizing a large administrative database as well as the risk of confounding by indication, as discussed above. Specifically, the NIS does not contain information about a patient's baseline neurological status and long-term outcome or about procedural details, such the particle size and type of embolic agent. However, the object of this study was to assess the overall risk of adverse in-hospital outcomes for preoperative embolization patients relative to that for nonembolization patients, and therefore we did not require this information. An additional limitation related to our study design is our assessment of preoperative embolizations only performed in the same admission as the craniotomy. In some cases, patients undergo embolization and are discharged for variable lengths of time before being readmitted for resection. Although this was probably true for only a minority of cases, these types of patients may have been misclassified as nonembolization patients, likely biasing comparisons between groups toward the null. Large database analyses of meningioma patients would be improved by the availability of longitudinal data on postdischarge complications and tumor recurrence. Furthermore, data on tumor characteristics such as size, feeding arteries, and location would enable more precise matching of embolization and nonembolization patients for analysis.
Conclusions
Meningiomas requiring preoperative embolization likely represent a distinct clinical entity with greater treatment complexity and higher risks. These findings have important implications for the management of and reimbursement structure for these complex tumors.
